Advertisement
News
Advertisement

Genzyme knee treatment approved in Japan

Mon, 09/20/2010 - 12:34pm
Mass High Tech: The Journal of New England Technology

Japanese regulators have approved an arthritis treatment developed by Genzyme Corp. The injection, called Synvisc, will be marketed by the Japanese company Teijin Pharma Ltd. and will be used to treat osteoarthritis of the knee.

Genzyme officials said that a recent study in Japan found that 30 million Japanese patients have osteoarthritis of the knee. Genzyme says Synvisc will be the first non-Japanese viscosupplement product approved in the country that can offer six months of pain relief with three injections. Genzyme plans to launch Synvisc in Japan by the end of this year.

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading